You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 24, December 28, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Cardiovascular System
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Continuing Anticoagulation Following Venous Thromboembolism—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Drs Krakow and Ortel that generalizability is important. Whether any study, be it a randomized controlled trial (RCT) or an epidemiologic study, can be applied to a given patient is a question of external validity. We recognize that RCT methodology limits external validity. However, the blanket statement that "the appropriate incidence rate ratio for bleeding is not one pooled from clinical trials, but from epidemiologic studies" is too broad.

Which set of data is more appropriate to use for any given decision depends in large part on the patient's characteristics and treatment context and how similar these are to those in the literature. Even studies using similar methods can report varying results because of population differences.1 For some patients, an RCT will provide a more relevant estimate of risk than an observational study. The same limitations apply to prediction rules, which can be derived from . . . [Full Text of this Article]

David Ost, MD, MPH
david.ost@med.nyu.edu
Department of Medicine
New York University School of Medicine
New York, NY



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Continuing Anticoagulation Following Venous Thromboembolism
Elizabeth Krakow and Thomas L. Ortel
JAMA. 2005;294(24):3088.
EXTRACT | FULL TEXT  

Duration of Anticoagulation Following Venous Thromboembolism: A Meta-analysis
David Ost, Josh Tepper, Hanako Mihara, Owen Lander, Raphael Heinzer, and Alan Fein
JAMA. 2005;294(6):706-715.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.